Clinical Trial: A prospective clinical study on the efficacy, safety and recurrence of oral isotretinoin in the treatment of moderate‑to‑severe acne with different doses, treatment stages and medication rhythms (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective clinical study on the efficacy, safety and recurrence of oral isotretinoin in the treatment of moderate‑to‑severe acne with different doses, treatment stages and medication rhythms'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132615

Registration Time: 2026/09/16

Type: Observational study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342374

Published by HT Digital Content Services with permission from Health Daily Digest....